CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

SENORES PHARMACEUTICALS LTD.

NSE : SENORESBSE : 544319ISIN CODE : INE0RB801010Industry : Pharmaceuticals & DrugsHouse : Private
BSE1052.3597.55 (+10.22 %)
PREV CLOSE () 954.80
OPEN PRICE () 969.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 46816
TODAY'S LOW / HIGH ()942.05 1062.00
52 WK LOW / HIGH ()491 1006.95
NSE1050.3595.7 (+10.02 %)
PREV CLOSE() 954.65
OPEN PRICE () 966.90
BID PRICE (QTY) 1050.35 (209)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1325468
TODAY'S LOW / HIGH() 941.00 1063.80
52 WK LOW / HIGH ()491 991
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2017

Management Info :

Sanjay Shaileshbhai Majmudar - Chairman Swapnil Jatinbhai Shah - Managing Director

Registered Office :

Address : 1101 To 1103, 11th Floor, South Tower,One 42 Opp. Jayantilal Park,Ambali Bopal Road,
Ahmedabad,
Gujarat-380054

Phone : 079-29999857

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
15May Senores Pharmaceuticals informs about
Senores Pharmaceuticals has informed regarding copy of Newspaper Publica..
04Apr Senores Pharmaceuticals informs about
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
09Mar Senores Pharmaceuticals informs about
Pursuant to Regulation 30(6) read with Schedule III of the Securities an..
21Jan Senores Pharmaceuticals informs about
Senores Pharmaceuticals has informed that it enclosed copy of Newspaper..
20Jan Senores Pharmaceuticals informs about
Senores Pharmaceuticals has informed that this is with reference to the..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit84.8202.5
Gross Profit 126.9 274.6
Operating Profit 187.1476.7
Net Sales 368.11060.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27934.60 (1.52%)
M.Cap ( in Cr)
59359.08
Pfizer (BSE)
 4939.05 (5.36%)
M.Cap ( in Cr)
22595.03
Astrazeneca Pharma I (BSE)
 8488.45 (1.66%)
M.Cap ( in Cr)
21221.13
Hester Biosciences (BSE)
 1834.05 (5.67%)
M.Cap ( in Cr)
1560.20
NGL Fine-Chem (BSE)
 2346.75 (3.90%)
M.Cap ( in Cr)
1449.83
Shareholding Pattern
PROMOTERS 45.82%
NON-INSTITUTION 40.93%
MUTUAL FUNDS/UTI 5.07%
FI/BANKS/INSURANCE 2.97%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX75237.99-160.73 (-0.21%)
NIFTY23643.50-46.10 (-0.19%)
Dow Jones 50063.46370.26 (0.75%)
Nasdaq 26635.22232.88 (0.88%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI